Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 1
2008 7
2009 7
2010 10
2011 7
2012 10
2013 8
2014 10
2015 12
2016 10
2017 6
2018 7
2019 11
2020 15
2021 17
2022 11
2023 20
2024 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

159 results

Results by year

Filters applied: . Clear all
Page 1
Update in the management of chronic thrombo-embolic pulmonary hypertension.
Ribas Sola J, Sánchez-Corral Mena MÁ, Riera-Mestre A. Ribas Sola J, et al. Among authors: riera mestre a. Med Clin (Barc). 2024 Feb 9;162(3):126-133. doi: 10.1016/j.medcli.2023.08.006. Epub 2023 Nov 2. Med Clin (Barc). 2024. PMID: 37925273 Free article. Review. English, Spanish.
Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome: A Randomized Noninferiority Trial.
Ordi-Ros J, Sáez-Comet L, Pérez-Conesa M, Vidal X, Riera-Mestre A, Castro-Salomó A, Cuquet-Pedragosa J, Ortiz-Santamaria V, Mauri-Plana M, Solé C, Cortés-Hernández J. Ordi-Ros J, et al. Among authors: riera mestre a. Ann Intern Med. 2019 Nov 19;171(10):685-694. doi: 10.7326/M19-0291. Epub 2019 Oct 15. Ann Intern Med. 2019. PMID: 31610549 Clinical Trial.
Editorial: Vascular malformations and thrombosis.
Di Micco P, Riera-Mestre A, Imbalzano E. Di Micco P, et al. Among authors: riera mestre a. Front Med (Lausanne). 2023 Jun 27;10:1196902. doi: 10.3389/fmed.2023.1196902. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37441692 Free PMC article. No abstract available.
Induced Endothelial Cell Cycle Arrest Prevents Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia.
Genet G, Genet N, Paila U, Cain SR, Cwiek A, Chavkin NW, Serbulea V, Figueras A, Cerdà P, McDonnell SP, Sankaranarayanan D, Huba M, Nelson EA, Riera-Mestre A, Hirschi KK. Genet G, et al. Among authors: riera mestre a. Circulation. 2024 Mar 19;149(12):944-962. doi: 10.1161/CIRCULATIONAHA.122.062952. Epub 2023 Dec 21. Circulation. 2024. PMID: 38126211
Translational medicine in hereditary hemorrhagic telangiectasia.
Riera-Mestre A, Cerdà P, Iriarte A, Graupera M, Viñals F. Riera-Mestre A, et al. Eur J Intern Med. 2022 Jan;95:32-37. doi: 10.1016/j.ejim.2021.09.003. Epub 2021 Sep 16. Eur J Intern Med. 2022. PMID: 34538686 Free article. Review.
New genetic drivers in hemorrhagic hereditary telangiectasia.
Cerdà P, Castillo SD, Aguilera C, Iriarte A, Rocamora JL, Larrinaga AM, Viñals F, Graupera M, Riera-Mestre A. Cerdà P, et al. Among authors: riera mestre a. Eur J Intern Med. 2024 Jan;119:99-108. doi: 10.1016/j.ejim.2023.08.024. Epub 2023 Sep 9. Eur J Intern Med. 2024. PMID: 37689549 Free article.
Medication regimen complexity: A new challenge.
Riera-Mestre A, Formiga F. Riera-Mestre A, et al. Rev Clin Esp (Barc). 2018 Oct;218(7):356-357. doi: 10.1016/j.rce.2018.06.005. Epub 2018 Jul 20. Rev Clin Esp (Barc). 2018. PMID: 30032931 English, Spanish. No abstract available.
The Impact of the Mediterranean Diet and Lifestyle Intervention on Lipoprotein Subclass Profiles among Metabolic Syndrome Patients: Findings of a Randomized Controlled Trial.
Candás-Estébanez B, Fernández-Cidón B, Corbella E, Tebé C, Fanlo-Maresma M, Esteve-Luque V, Salas-Salvadó J, Fitó M, Riera-Mestre A, Ros E, Pintó X. Candás-Estébanez B, et al. Among authors: riera mestre a. Int J Mol Sci. 2024 Jan 22;25(2):1338. doi: 10.3390/ijms25021338. Int J Mol Sci. 2024. PMID: 38279337 Free PMC article. Clinical Trial.
36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE.
Turpie AGG, Farjat AE, Haas S, Ageno W, Weitz JI, Goldhaber SZ, Goto S, Angchaisuksiri P, Kayani G, Lopes RD, Chiang CE, Gibbs H, Tse E, Verhamme P, Ten Cate H, Muntaner J, Schellong S, Bounameaux H, Prandoni P, Maheshwari U, Kakkar AK; GARFIELD-VTE investigators. Turpie AGG, et al. Thromb Res. 2023 Feb;222:31-39. doi: 10.1016/j.thromres.2022.11.016. Epub 2022 Nov 25. Thromb Res. 2023. PMID: 36565677 Free article.
159 results